Ipsen S.A. (EPA:IPN)
158.20
+0.90 (0.57%)
At close: Feb 19, 2026
Ipsen Market Cap
Ipsen has a market cap or net worth of €12.91 billion as of February 19, 2026. Its market cap has increased by 27.89% in one year.
Market Cap
12.91B
Enterprise Value
12.27B
Revenue
3.93B
Ranking
n/a
PE Ratio
29.57
Stock Price
€158.20
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 12.91B, an increase of 627.16%. That is a compound annual growth rate of 10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 12.91B | 32.18% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 113.81B |
| Sanofi | 93.53B |
| Sartorius Stedim Biotech | 17.02B |
| Eurofins Scientific SE | 11.40B |
| bioMérieux | 10.89B |
| ABIVAX Société Anonyme | 8.37B |
| Virbac | 3.01B |
| emeis Société anonyme | 2.35B |